Globus Medical Shares Fall After Missing 1Q Estimates, Trimming Earnings Outlook

Dow Jones

May 09, 2025

By Connor Hart

Shares of Globus Medical tumbled after the company posted lower-than-expected earnings and sales in the first quarter, hurt in part by completing fewer deals and supply-chain snarls.

The company also cut its adjusted earnings outlook.

The stock sank 18%, to $59.41, in after-hours trading. Through Thursday's close, shares have gained 13% in the past year, despite having lost 18% of their value over the past three months.

The medical device company after the bell posted a profit of $75.5 million, or 54 cents a share, for the March quarter, compared with a loss of $8 million, or 5 cents a share, a year earlier.

Adjusted per-share earnings of 68 cents came in below the 74 cents that analysts surveyed by FactSet expected.

Revenue fell 1.2% to $598.1 million and missed the $625.9 million that analysts modeled.

Chief Executive Dan Scavilla said the recent quarter was hurt by softer deal closures, temporary integration-related supply-chain disruptions, and the timing of international distributor orders.

Globus Medical now expects adjusted per-share earnings of $3 to $3.30 for the year, down from a prior outlook of $3.10 to $3.40. It backed its full-year sales forecast of $2.8 billion to $2.9 billion.

Analysts are looking for adjusted earnings of $3.44 a share on revenue of $2.68 billion.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

May 08, 2025 18:43 ET (22:43 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2534819564"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2534819564\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2534819564?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 06:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534819564","market":"fut","top_or_hot":-1,"title":"Globus Medical Shares Fall After Missing 1Q Estimates, Trimming Earnings Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Globus Medical tumbled after the company posted lower-than-expected earnings and sales in the first quarter, hurt in part by completing fewer deals and supply-chain snarls. \n</p>\n<p>\n  The company also cut its adjusted earnings outlook. \n</p>\n<p>\n  The stock sank 18%, to $59.41, in after-hours trading. Through Thursday's close, shares have gained 13% in the past year, despite having lost 18% of their value over the past three months. \n</p>\n<p>\n  The medical device company after the bell posted a profit of $75.5 million, or 54 cents a share, for the March quarter, compared with a loss of $8 million, or 5 cents a share, a year earlier. \n</p>\n<p>\n  Adjusted per-share earnings of 68 cents came in below the 74 cents that analysts surveyed by FactSet expected. \n</p>\n<p>\n  Revenue fell 1.2% to $598.1 million and missed the $625.9 million that analysts modeled. \n</p>\n<p>\n  Chief Executive Dan Scavilla said the recent quarter was hurt by softer deal closures, temporary integration-related supply-chain disruptions, and the timing of international distributor orders. \n</p>\n<p>\n  Globus Medical now expects adjusted per-share earnings of $3 to $3.30 for the year, down from a prior outlook of $3.10 to $3.40. It backed its full-year sales forecast of $2.8 billion to $2.9 billion. \n</p>\n<p>\n  Analysts are looking for adjusted earnings of $3.44 a share on revenue of $2.68 billion. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 08, 2025 18:43 ET (22:43 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Globus Medical Shares Fall After Missing 1Q Estimates, Trimming Earnings Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobus Medical Shares Fall After Missing 1Q Estimates, Trimming Earnings Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-09 06:43</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Globus Medical tumbled after the company posted lower-than-expected earnings and sales in the first quarter, hurt in part by completing fewer deals and supply-chain snarls. \n</p>\n<p>\n  The company also cut its adjusted earnings outlook. \n</p>\n<p>\n  The stock sank 18%, to $59.41, in after-hours trading. Through Thursday's close, shares have gained 13% in the past year, despite having lost 18% of their value over the past three months. \n</p>\n<p>\n  The medical device company after the bell posted a profit of $75.5 million, or 54 cents a share, for the March quarter, compared with a loss of $8 million, or 5 cents a share, a year earlier. \n</p>\n<p>\n  Adjusted per-share earnings of 68 cents came in below the 74 cents that analysts surveyed by FactSet expected. \n</p>\n<p>\n  Revenue fell 1.2% to $598.1 million and missed the $625.9 million that analysts modeled. \n</p>\n<p>\n  Chief Executive Dan Scavilla said the recent quarter was hurt by softer deal closures, temporary integration-related supply-chain disruptions, and the timing of international distributor orders. \n</p>\n<p>\n  Globus Medical now expects adjusted per-share earnings of $3 to $3.30 for the year, down from a prior outlook of $3.10 to $3.40. It backed its full-year sales forecast of $2.8 billion to $2.9 billion. \n</p>\n<p>\n  Analysts are looking for adjusted earnings of $3.44 a share on revenue of $2.68 billion. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 08, 2025 18:43 ET (22:43 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GMED","symbol_name":"Globus Medical Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2534819564","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534819564","pubTimestamp":1746744180,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Globus Medical tumbled after the company posted lower-than-expected earnings and sales in the first quarter, hurt in part by completing fewer deals and supply-chain snarls.The company also cut its adjusted earnings outlook.The stock sank 18%, to $59.41, in after-hours trading. Through Thursday's close, shares have gained 13% in the past year, despite having lost 18% of their value over the past three months.The medical device company after the bell posted a profit of $75.5 million, or 54 cents a share, for the March quarter, compared with a loss of $8 million, or 5 cents a share, a year earlier.Adjusted per-share earnings of 68 cents came in below the 74 cents that analysts surveyed by FactSet expected.Revenue fell 1.2% to $598.1 million and missed the $625.9 million that analysts modeled.Chief Executive Dan Scavilla said the recent quarter was hurt by softer deal closures, temporary integration-related supply-chain disruptions, and the timing of international distributor ord","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"GMED":"Globus Medical Inc"},"translate_title":"Globus Medical股价因未达到第一季度预期而下跌，下调盈利前景","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GMED":1},"content_text":"By Connor Hart \n\n\n \n\n\n  Shares of Globus Medical tumbled after the company posted lower-than-expected earnings and sales in the first quarter, hurt in part by completing fewer deals and supply-chain snarls. \n\n\n  The company also cut its adjusted earnings outlook. \n\n\n  The stock sank 18%, to $59.41, in after-hours trading. Through Thursday's close, shares have gained 13% in the past year, despite having lost 18% of their value over the past three months. \n\n\n  The medical device company after the bell posted a profit of $75.5 million, or 54 cents a share, for the March quarter, compared with a loss of $8 million, or 5 cents a share, a year earlier. \n\n\n  Adjusted per-share earnings of 68 cents came in below the 74 cents that analysts surveyed by FactSet expected. \n\n\n  Revenue fell 1.2% to $598.1 million and missed the $625.9 million that analysts modeled. \n\n\n  Chief Executive Dan Scavilla said the recent quarter was hurt by softer deal closures, temporary integration-related supply-chain disruptions, and the timing of international distributor orders. \n\n\n  Globus Medical now expects adjusted per-share earnings of $3 to $3.30 for the year, down from a prior outlook of $3.10 to $3.40. It backed its full-year sales forecast of $2.8 billion to $2.9 billion. \n\n\n  Analysts are looking for adjusted earnings of $3.44 a share on revenue of $2.68 billion. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2025 18:43 ET (22:43 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}